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Abstract 
We have studied the thermotropic properties of a wide variety of cannabinoids in DPPC bilayers. The molecules under study were 
divided into four classes: (a) classical cannabinoids possessing a phenolic hydroxyl group; (b) Ag-THC metabolites with an additional 
hydroxyl group on the C ring; (c) non-classical cannabinoids, and (d) cannabinoids with a protected phenolic hydroxyl group. The results 
showed that the first three groups have similar effects on the thermotropic properties of DPPC bilayers up to x = 0.05 (molar ratio) and 
that these effects do not parallel their biological activity. For concentrations less than x = 0.01, cannabinoids affect mainly the 
pretransition temperature in a progressive manner until its final abolishment. At x = 0.05, they further affect he main phase transition by 
lowering its phase transition temperature and broadening its half width. At high concentrations the thermograms have multiple 
components, indicating that membranes are no longer homogeneous but rather consist of different domains. At these concentrations 
cannabinoids with more hydroxyl groups give simpler thermograms. Low concentrations of cannabinoids in group d affect significantly 
the pretransition temperature, while high concentrations affect only marginally the main phase transition by slightly lowering its 
temperature and broadening its half width. These results point out the importance of the phenolic hydroxyl group in inducing membrane 
perturbations. The d-spacing data from our small angle X-ray diffraction experiments show that A8-THC produces ignificant structural 
changes in the lipid bilayer, including the gel-phase tilting angle, the intermolecular cooperativity and the gauche:trans conformer ratio. 
Conversely, the inactive analog Me-A8-THC does not cause drastic changes to the bilayer structure. 
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I. Introduction 
Existing evidence suggests that not all physiological 
effects of cannabinoids can be attributed to the existence 
of cannabinoid receptors but some can be related to their 
effects on cellular membranes [1,2]. More specifically, 
cannabinoids produce biochemical changes in a variety of 
membrane preparations at concentrations which are ar- 
Abbreviations: DSC, differential scanning calorimetry ; DPPC, dipal- 
mitoylphosphatidylcholine; A8-THC, (-)-AS-tetrahydrocannabinol; Me- 
/tS-THC, O-methyl-AS-tetrahydrocannabinol. 
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guably 'physiological' [3,4] and affect numerous mem- 
brane-related functions. They also exert non-receptor me- 
diated effects on membrane-bound enzymes uch as: Na ÷- 
K+-Mg 2÷- and Ca2+-ATPases [5-7], NADH dehydro- 
genase [8], lysophosphatidylcholine acyl transferase [9], 
phospholipase A 2 [10], monoamine oxidase [11] and 
adenylate cyclase [12]. Additionally, cannabinoids affect 
the function of neurotransmitter uptake systems [6], blood 
platelets [13], human lung fibroblast [14], neutrophils [ 15] 
and certain non-cannabinoid receptors [1,2] The cannabi- 
noids are lipophilic molecules and are believed to interact 
firstly on the lipid microenvironment surrounding the 
membrane-associated enzymes [16,17]. The cannabinoid- 
membrane interactions presumably induce changes in the 
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Fig. 1. Chemical structures of the cannabinoids under study. 
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functions of a number of these proteins and thus alter a 
variety of physiological functions. Experimental evidence 
for such a mechanism of action involving cannabinoid- 
phospholipid interactions came from calorimetric and fluo- 
rescence measurements [18-20], electron spin resonance 
experiments [21], ~H-NMR [22] and solid state 2H-NMR 
[23-26]. 
Differential scanning calorimetry (DSC) is a relatively 
inexpensive thermodynamic technique which allows us to 
study the thermotropic properties of membranes in the 
absence and presence of biologically active molecules. 
DSC was used by Bach and his collaborators [18] to 
investigate the interactions of A9-tetrahydrocannabinol 
(Ag-THC) the principal active ingredient of cannabis and 
cannabidiol in DPPC and calf brain lipid bilayers. They 
found that both drugs affected the transition of DPPC from 
gel to liquid crystal and the enthalpy of this transition in 
the same manner. The same authors presented evidence 
from DSC and enzymatic activity measurements that A 9- 
THC also affected the thermotropic properties of liver 
microsomal membranes and microsomal lipids. 
DSC was used by Burstein et al. to study the differ- 
ences between the inactive ( + )-A9-THC and the psychoac- 
tive (-)-A9-THC [20]. Both enantiomers induce some 
general perturbation of the melting behavior of the DPPC 
bilayer but at different concentrations. For the biologically 
active enantiomer the enthalpy of transition (AH) never 
decreased, in contrast o the inactive one where the en- 
thalpy of transition diminished for THC concentrations 
above the lipid/drug molar ratio of 80:20 (x = 0.20). 
Bruggeman and Melchior [19] used DSC to study the 
interactions of A9-THC with various phosphatidylcholines. 
The most significant results of this study are as follows: 
(a) Addition of THC broadens the main transition and 
gradually lowers its temperature. (b) The addition of THC 
creates a sharp, distinct peak several degrees below that of 
the original main transition. This is interpreted as the 
formation of a phospholipid:THC complex. (c) The en- 
thalpy (AH) of the entire transition is equal to or less than 
that of the main transition of pure PC. (d) Above a certain 
characteristic molar fraction (x = 0.23) of THC, the ap- 
pearance of the transition does not change significantly. 
This observation is due to the limit of incorporation of the 
cannabinoid in the phospholipid bilayer. (e) The presence 
of cholesterol below x = 0.20 in DPPC bilayers enhanced 
THC:DPPC complex formation while above x = 0.20 this 
was not evident. 
Earlier DSC work from our laboratory using high con- 
centrations of AS-THC and Me-AS-THC showed that only 
A8-THC complexes with DPPC [27]. Other DSC work 
from our laboratory also showed that 8 c~ and 8/3-hydroxy- 
A9-tetrahydrocannabinols (two metabolites of the naturally 
occurring A9-THC strongly affected the melting behavior 
of hydrated DPPC bilayers, inducing a lowering of the 
main transition temperature, a broadening of that transition 
and the abolishment of the pretransition [28]. 
In this study we examined the thermotropic properties 
of a wide variety of cannabinoids possessing a wide range 
of pharmacological potencies (Fig. 1) on DPPC membrane 
bilayers. The cannabinoids used were classified into four 
groups: (a) classical cannabinoids possessing a phenolic 
hydroxyl group; (b) classical cannabinoids with an addi- 
tional hydroxyl group on the C-ring (Ag-THC metabolites); 
(c) tricyclic analogs with three hydroxyl groups (non- 
classical cannabinoids); (d) classical cannabinoids with a 
protected phenolic hydroxyl group. 
The aim of this study was two-fold: First, to examine 
the role of phospholipids in the interactions of cannabi- 
noids with the membrane bilayers, and second, to investi- 
gate any structure activity relationships using thermogram 
parameters ( AH, T m, T~.j/2). 
2. Materials and methods 
2.1. Materials 
Cannabinoids coded as AMGs (Fig. l) were synthesized 
in our laboratory. Details of their synthesis will be dis- 
cussed elsewhere. The rest of the cannabinoids were kindly 
provided by NIH. DPPC was purchased from Avanti Polar 
Lipids, Birmingham, AL. 
2.2. Sample preparation 
DPPC alone or with the appropriate amount of cannabi- 
noid were dissolved in chloroform (99 + % pure, Aldrich 
Chemical Co., Milwaukee, WI). The solvent was then 
removed using an O2-free N 2 stream and the samples were 
dried under high vacuum for 6 h. 
2.3. Differential scanning calorimetry 
After adding distilled water (50% w/w), a portion of 
the sample (ca. 5 mg) was sealed in a stainless steel 
capsule. Thermograms were obtained on a Perkin-Elmer 
DSC 2 and DSC 7 instruments. Prior to scanning, the 
samples were held above their phase transition temperature 
for 1-2 rain to ensure complete quilibration. All samples 
were scanned at least twice until identical thermograms 
were obtained using a scanning rate of 2.5°C/min. The 
temperature scale of the calorimeter was calibrated using 
fully hydrated DPPC and indium as standard samples. We 
found that the thermograms from samples tored at freezer 
temperatures ( - 15°C) for a few days were identical if run 
immediately after sample preparation. 
2.4. Small angle X-ray diffraction 
Another smaller portion (ca. 2 mg) of each hydrated 
sample was drawn into a thin-walled capillary tube (inner 
diameter 0.5 mm) which was then sealed at both ends. 
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X-ray diffraction experiments were carried out with an 
Elliott GX 18 generator (Marconi Avionics), equipped with 
a camera utilizing a single vertical Franks' mirror [29]. 
Small angle X-ray diffraction patterns were collected using 
a Braun one-dimensional, position-sensitive proportional 
counter (PSPC) gas flow detector (Innovative Technology, 
Inc., Newburyport, MA). During the experiment, we used 
a helium path for a specimen-to-detector distance of 210 
mm and collected the diffraction data with digital accumu- 
lations of 1 × 10 6 to 2 × 10 6 counts to improve the signal- 
to-noise ratio. Data was transferred to a VAX 8200 (Dig- 
ital Equipment Corporation) computer system where the 
d-spacings were calculated. 
3. Results and discussion 
3.1. Classical cannabinoids possessing a phenolic hy- 
droxyl group 
A8-THC an analog equipotent with A9-THC but chemi- 
cally more stable was used as a parent compound in this 
group [30]. Normalized thermograms of DPPC prepara- 
tions containing increasing concentrations of AS-THC are 
shown in Fig. 2. The thermogram of pure DPPC indicates 
a pretransition centered at 35°C while the onset and the 
peak maximum (T c) for the main transition occurs at 
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Fig. 2. Normalized ifferential scanning calorimetry thermograms of fully 
hydrated bilayers of DPPC with or without A8-THC. 
x = 0.001), AS-THC produces a slight broadening of the 
pretransition and shifting to a lower temperature while the 
main transition remains unaffected. At x = 0.01 the broad- 
ening of the pretransition becomes more pronounced and 
almost coalesces with main transition. At x = 0.05, A s_ 
THC produces an elimination of the pretransition and a 
shift of T~ to 39.6°C. At x = 0.10 the main transition 
temperature is further lowered to 38°C while two new 
broad peaks appear in the thermogram at lower tempera- 
tures. At x = 0.20, the middle peak intensifies and be- 
comes dominant in the thermogram. The appearance of 
this latter peak is interpreted to be due to the formation of 
a THC:DPPC complex [19,23,28]. AS-THC/DPPC bilayer 
samples show identical thermograms to those obtained 
from Ag-THC/DPPC bilayers at corresponding molar ra- 
tios [23]. 
We then examined and compared the effects of struc- 
turally related analogs possessing a wide range of biologi- 
cal potencies. Normalized thermograms of DPPC prepara- 
tions containing increasing concentrations of the phar- 
macologically inactive analog A9']I-THC (left) and the 
highly potent 5'-Br-AS-THC (right) are shown in Fig. 3. 
The results are similar to those observed with the A 8- 
THC/DPPC bilayers. These results lead to the conclusion 
that the pharmacological potencies of cannabinoids cannot 
be directly correlated with their membrane-perturbing ef- 
fects, 
This conclusion is further supported by the results 
obtained with the potent cannabinoid AMG-5 (Fig. 4, 
right) and the almost inactive AMG-16 (Fig. 4, left), both 
of which are A8-THC analogs with side chains modified 
respectively to an a-ketohexyl or an a-keto-naphthyl sub- 
stituent. Both molecules exert similar thermotropic effects 
on DPPC bilayers as AS-THC (Fig. 2). 
We have also examined the effects of AMG-3 (Fig. 5, 
right) and AMG-7 (Fig. 5, left) two side chain analogs of 
AS-THC on DPPC bilayers and found only small differ- 
ences with those of ALTHC. AMG-3 which incorporates a 
dithiolane ring in the 1' position of an n-heptyl side chain 
is a potent cannabinoid while AMG-7 in which the six 
carbon chain of AMG-3 has been removed is almost 
devoid of cannabimimetic a tivity. Small differences were 
observed only with preparations of x = 0.01 and x = 0.05 
when compared to the corresponding DPPC/AS-THC 
samples. Both AMG-3 or AMG-7 produced more complex 
thermograms a manifested by the shoulder to the right of 
the main peak. In the case of AS-THC, only a broadening 
is observed at these drugs concentrations but no separate 
shoulder. 
It appears from the above results that the alkyl side 
chain of the cannabinoids does not play an important role 
in the DPPC:cannabinoid nteractions because its substitu- 
tion with other hydrophilic or hydrophobic moieties or 
even its absence in the cannabinoid structure does not alter 
significantly the thermotropic effects of cannabinoids on 
DPPC bilayers. 
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Fig. 3. Normalized ifferential scanning calorimetry thermograms of fully hydrated bilayers of DPPC with or without ,.19"~ -THC (left) and DPPC with or 
without 5'-Br-A8-THC (right). 
3.2. Metabol i tes  o f  THC 
We have compared the effects of three metabolites of 
A9-THC, namely l l -OH-,  8ol-OH- and 8/3-OH-A9-THC 
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Fig. 4. Normalized differential scanning calorimetry thermograms of fully 
hydrated bilayers of DPPC with or without AMG-16 (left) and DPPC 
with or without AMG-5 (right). 
on DPPC bilayers. 1 I-OH-Ag-THC is a biologically active 
metabolite of Ag-THC which is more potent than the 
parent compound. 8/3-OH-A9-THC is pharmacologically 
active but less potent than Ag-THC, whereas 8o~-OH-A 9- 
H 
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Fig. 5. Normalized ifferential scanning calorimetry thermograms of fully 
hydrated bilayers of DPPC with or without AMG-7 (left) and DPPC with 
or without AMG-3 (right). 
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THC is an almost inactive epimer. The choice of these 
three metabolites allowed us to examine the significance of 
a second hydroxyl group with regard to the effects of 
cannabinoid analogs on membranes. The thermotropic ef- 
fects of 8fl-OH-A9-THC and 8a-OH-Ag-THC have al- 
ready been reported in detail in a previous publication [28]. 
However, a brief description of these results is included 
here for the sake of completeness. 
At x = 0,05 and x = 0.10 cannabinoid concentrations 
(Fig. 6), the two preparations showed similar thermotropic 
behavior to those containing AS-THC (Fig. 2). However, 
at x = 0.20, the DPPC preparation containing the epimeric 
two compounds produced ifferent hermograms from that 
of A9-THC/DPPC. Of the two peaks observed, the low 
temperature one was more pronounced in the case of 
8/3-OH-A9-THC than in 8a-OH-A9-THC. The thermo- 
gram of A9-THC/DPPC at x = 0.20 (identical with that 
of AS-THC/DPPC) is similar to that of 8fl-OH-Ag-THC. 
These results show that the position of the hydroxyl group 
on the C-ring plays an important role in the interaction of 
the two epimeric annabinoids with the DPPC bilayers. 
Normalized thermograms of DPPC preparations con- 
taining increasing concentrations of 11-OH-A9-THC are 
shown in Fig. 7. The effects of this metabolite resemble 
those of 8 c~-OH-A9-THC and differ from those of 8/3-OH- 
A9-THC. These results may reflect the similar orientation 
of the C-ring hydroxyl group of DPPC/8c~-OH-A9-THC 
and DPPC/1 I-OH-Ag-THC within the bilayer. They also 
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Fig. 7. Normalized ifferential scanning calorimetry thermograms of fully 
hydrated bilayers of DPPC with or without 1 I-OH-A9-THC. 
plays an important role in the thermotropic effects of the 
cannabinoids in the membrane bilayers. 
3.3. Non-classical cannabinoids 
We compared the thermotropic effects of the potent 
non-classical cannabinoid CP 55,243 and its inactive nan- 
tiomer CP 55,244 (Fig. 8) on the thermal properties of 
DPPC bilayers. These molecules which were synthesized 
at Pfizer as potential analgesic agents differ from the 
naturally occurring tetrahydrocannabinols and their 
metabolites by (a) the absence of tetrahydropyran ri g, (b) 
having a longer 1,1-dimethylheptyl side chain, and (c) the 
presence of a hydroxyl group which is attached to a 
cyclohexyl component corresponding to the C-ring of the 
natural cannabinoids [31,32]. Although the non-classical 
cannabinoids were principally tested for analgesic activity 
[33], there is enough data indicating that they also exhibit 
animal behavioral effects imilar to those of the 'classical' 
analogs [34]. 
The incorporation of the two enantiomers into DPPC 
bilayers resulted in identical thermograms. These results 
indicate that the phospholipid environment, although 
asymmetric, does not interact differently in any observable 
fashion with the two non-classical cannabinoid enan- 
tiomers. 
It is interesting to note that all three groups of analogs 
so far studied show small differential effects up to x = 0.05. 
Above this concentration their differential effects are en- 
hanced. A possible reason for this is that above this 
concentration the cannabinoids produce different domains 
within the bilayer as indicated by the appearance of new 
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Fig. 8. Normalized differential scanning calorimetry thermograms of fully hydrated bilayers of DPPC with or without CP55,243 (left) and DPPC with or 
without CP55,244 (right). 
peaks. The extent to which these domains are formed 
varies with the different analogs. We also observed a trend 
that suggests that the more hydrophilic the cannabinoid 
(more hydroxyl groups), the lesser its tendency for produc- 
ing domains. These results also suggest that at low concen- 
trations < x = 0.05 the cannabinoids are incorporated at 
the same location in membrane bilayer where they exert 
'similar membrane-perturbing effects'. Our results may 
also reflect the experimental limitations in designing bio- 
physical experiments for studying drug perturbations and 
relating these results to pharmacological potency. Appar- 
ently, the 'perturbations' induced by the cannabinoid 
molecules at very low concentrations are not significant 
enough to be differentiated by this method. Details on 
these experimental uncertainties are described elsewhere 
[35]. 
3.4. Classical cannabinoids with a protected phenolic 
hydroxyl group 
It is well known that the phenolic hydroxyl group of a 
cannabinoid is a strict requirement for cannabimimetic 
activity and methylation of this group to give the O-methyl 
ether esults in an analog devoid of biological activity [36]. 
Earlier work from our laboratory [24] compared the effects 
of the pharmacologically active AS-THC possessing a 
phenolic hydroxyl group with its inactive O-methyl analog 
(Me-AS-THC) at high concentrations (Fig. 1). In these 
studies we showed, using DSC and solid state eH-NMR, 
that the phenolic -OH in AS-THC allows it to interact with 
the membrane at the bilayer interface, whereas this was not 
observed with Me-AS-THC. Solid state 2 H-NMR data have 
also shown that A8-THC orients with the long axis of its 
tricyclic structure perpendicular to the bilayer chains. Con- 
versely, Me-A8-THC was shown to assume an orientation 
in which the long axis of the tricyclic structure is parallel 
to the lipid chains. 
Thermograms for Me-A8-THC/DPPC preparations at 
low and high concentrations are shown in Fig. 9. The 
effects of this molecule on the DPPC bilayers differ sharply 
from those of classical and non-classical cannabinoids 
which contain a free phenolic hydroxyl group. At x = 
0.001, Me-A8-THC broadens the pretransition but does not 
affect the main transition and at x = 0.01, the pretransition 
is further broadened. The main transition has the same 
half-width as that of the pure DPPC with only a small 
decrease in Tc. At higher drug concentrations (x = 0.05, 
x=0.10  and x= 0.20), no major change in the DPPC 
thermograms was observed. There is no appreciable change 
in the onset temperature of the main transition; only a 
progressive broadening of the transition occurs and a 
shoulder appears at the low temperature end when x = 
0.20. The respective O-methyl dithiolane analog (AMG- 18) 
exerts similar thermotropic effects when incorporated in 
DPPC bilayer preparations a  those with Me-AS-THC (Fig. 
9, right). 
A similar effect on the thermotropic properties of DPPC 
bilayers is exhibited by the analgesic nantradol [22] in 
which the phenolic hydroxyl is acetylated. It is generally 
believed that during metabolism the acetyl group is hydro- 
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Fig. 9. Normalized ifferential scanning calorimetry thermograms of fully 
hydrated bilayers of DPPC with or without Me-A8-THC (left) and DPPC 
with or without AMG-18 (right). 
lyzed to an analog with a free phenolic hydroxyl which is 
also responsible for its biological effects. The thermograms 
of the DPPC/nantradol preparations again resemble those 
of the Me-A8-THC samples (see Fig. 10). At a very high 
drug concentration (x= 0.20) this preparation did not 
OH 0 0 CH s 
"3 Na~tr~dol ] \ 
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Fig. 10. Normalized differential scanning calorimetry thermograms of 
fully hydrated bilayers of DPPC with or without Nantradol. 
produce any inhomogeneity in the model membrane proba- 
bly because of the high lipophilic character of the drug 
molecule. 
For all cannabinoid/DPPC concentrations studied, the 
enthalpy for DPPC did not change significantly and was 
similar to that observed for pure DPPC within experimen- 
tal error. 
The above results do not allow any correlations between 
the effects of cannabinoids on the thermotropic properties 
of membranes and their pharmacological potencies. This 
leads to the conclusion that the membrane-perturbing ef- 
fect of cannabinoids cannot fully account for their biologi- 
cal activities. 
4. X-ray diffraction 
In an effort to better understand the observed ifferent 
thermotropic effects between classical cannabinoids lack- 
ing the phenolic hydroxyl group with the rest of the 
groups, we used small angle X-ray diffraction on DPPC 
preparations without or with A8-THC and Me-A8-THC. 
Small angle X-ray diffraction patterns from fully hy- 
drated bilayer preparations of both DPPC with and without 
AS-THC and Me-AS-THC at various temperatures were 
obtained and analyzed. Two diffraction peaks were ob- 
served on each side of the main incident beam which was 
kept from reaching the detector by a small beam-stop. 
These peaks were indexed to be h = 1 and h = 2 on the 
left and h = -1  and h = -2  on the right according to 
Bragg's law 2dsin0= hA. By measuring the exact loca- 
tions of the peaks in the diffraction pattern, we calculated 
the unit-cell repeat distance (d-spacing). Values of d-spac- 
ing for fully hydrated preparations of DPPC alone, 
DPPC/ (x= 0.20) AS-THC and DPPC/ (x=0.20)  Me- 
AS-THC are shown in Fig. 11. For the DPPC preparation, 
our measured -spacing values and their temperature de- 
pendence were consistent with results reported previously 
[37]. For the DPPC bilayer, the d-spacing increases as the 
temperature rises, reaches a maximum near the gel-to- 
liquid-crystal phase transition, and then decreases after 
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Fig. It. d-spacing of fully hydrated DPPC bilayer preparations in the 
absence and presence of A8-THC (x = 0.20) and Me-AS-THC (x = 0.20). 
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toring the d-spacing variation with temperature, we can 
observe the maximum d-spacing and the corresponding 
temperature at which the bilayer preparation is on the 
verge of the phase transition. The temperature d pendence 
of the d-spacings provides information on the phase transi- 
tion properties complementary to that obtained from DSC 
thermograms. 
When the biologically active AS-THC (x = 0.20) is 
incorporated into DPPC bilayers, the d-spacing is 8 ,~ 
larger than that of pure DPPC in the temperature ange 
below the phase transition. Also, its temperature depen- 
dence diagram exhibits a broader peak with the maximum 
point occurring at 32°C, i.e., 8°C below the corresponding 
temperature for pure DPPC. Conversely, the d-spacing of 
the DPPC preparation containing the inactive Me-A8-THC 
shows a temperature d pendence almost identical to that of 
pure DPPC. The location of the maximum and the width of 
the peak are exactly the same as observed from pure 
DPPC. The only noticeable difference is that the d-spacing 
values of DPPC + Me-A8-THC at all temperatures are 
consistently higher than those of DPPC by 2 to 3 ,~ as we 
have shown in previous publications [38-40] 
The d-spacing data from our small angle X-ray diffrac- 
tion experiments show that AS-THC produces ignificant 
structural changes in the lipid bilayer, including the gel- 
phase tilting angle, the intermolecular cooperativity and 
the gauche/trans conformer ratio. On the other hand, the 
inactive analog does not seem to change the bilayer struc- 
ture except hat it increases the d-spacing values by about 
2 to 3 A. This effect may be caused by the presence of 
Me-AS-THC in the center (terminal methyl region) of the 
bilayer [38,39]. This observation is congruent with our 
previous X-ray results in partially hydrated bilayers show- 
ing that this analog resides in the center of the bilayer. In 
contrast, the active analog did not show such an increase. 
This again agrees with our previous results showing this 
cannabinoid to intercalate at the interface of the bilayer 
[40]. 
5. Conclusions 
We were able to show that cannabinoids possessing a
phenolic hydroxyl group induce distinct changes in the 
thermotropic properties of a model membrane preparation 
as compared to cannabinoids without a free phenolic hy- 
droxyl which produce only marginal thermotropic effects. 
This points out the important role of the phenolic hydroxyl 
for perturbing a membrane bilayer. 
We observed some differences among the various 
classes of cannabinoids in their effects on model mem- 
brane preparations. These differences became more pro- 
nounced with increasing drug concentrations. As a general 
trend, the more hydroxylated cannabinoids showed fewer 
endotherms in their thermograms, an observation which 
may be attributed to the increased polar character of these 
molecules. The comparison between the two non-classical 
enantiomeric cannabinoids showed that they exert similar 
effects on the thermotropic properties of DPPC bilayers 
which, although asymmetric, appear not to discriminate 
between two enantiomers. 
We are currently using DSC to study the differences 
between the effects of AS-THC and Me-AS-THC on the 
thermotropic properties of other lipid bilayers. Such exper- 
iments will provide evidence of any specific interactions 
between the drug molecules and their membrane ffects. 
We are also studying the effects of the above molecules on 
membranes containing cholesterol. These preparations re- 
semble more closely the biological membranes. Such data 
combined with those obtained here would give us more 
detailed information on perturbing effects of these 
molecules on membranes. Our inability to detect any sig- 
nificant differences between several cannabinoids using 
DSC may be due to that these differences are too small to 
be detected by this technique. It remains to be examined if
insertion of cholesterol magnifies these differences. Details 
with these results will be published elsewhere. 
The small angle X-ray diffraction experiments show 
that the incorporation of AS-THC in hydrated DPPC 
preparations produces ignificant structural changes on the 
bilayer structure. Conversely, the inactive analogs in which 
the phenolic OH is substituted do not seem to significantly 
affect the properties of the bilayer except hat they lead to 
an increase in the d-spacing values. This result validates 
earlier data from our laboratory showing that Me-AS-THC 
resides in the center of the bilayer in partially hydrated 
DMPC bilayers and is responsible for the increase of the 
d-spacing. Unlike AS-THC that anchors in the interface of 
the bilayer and does not increase the d-spacing. 
It appears that the biological activity of the cannabi- 
noids cannot simply be explained by their interactions with 
phospholipid bilayers. However, their important role is 
established since significant differences between the groups 
with and without phenolic hydroxyl group were observed. 
Their different perturbation may at least in part explain 
their inability to exert any biological activity. However, for 
the other classes the cannabinoid:receptor interaction may 
be the decisive factor for cannabinoid activity. 
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